Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers


  Free Subscription


11 Ann Intern Med
1 Antimicrob Agents Chemother
1 Epidemiol Infect
1 J Epidemiol Community Health
1 J Exp Med
3 J Immunol
1 J Infect
4 J Virol
6 J Virol Methods
5 Lancet
1 Lancet Planet Health
5 MMWR Morb Mortal Wkly Rep
8 N Engl J Med
1 PLoS Biol
18 PLoS One
1 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. TIWARI V, Bhardwaj A, Sonani B, Mehta AC, et al
    Urgent Issues Facing Immigrant Physicians in the United States in the COVID-19 Era.
    Ann Intern Med. 2020 Jul 2. doi: 10.7326/M20-4103.

  2. MALHAME I, D'Souza R, Cheng MP
    The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19.
    Ann Intern Med. 2020 Jun 29. doi: 10.7326/M20-3106.

  3. GLADSTONE DE, Kim BS, Mooney K, Karaba AH, et al
    Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
    Ann Intern Med. 2020 Jul 6. doi: 10.7326/L20-0681.

  4. GOYAL P, Ringel JB, Rajan M, Choi JJ, et al
    Obesity and COVID-19 in New York City: A Retrospective Cohort Study.
    Ann Intern Med. 2020 Jul 6. doi: 10.7326/M20-2730.

  5. PHAM TD, Huang C, Wirz OF, Roltgen K, et al
    SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution.
    Ann Intern Med. 2020 Jul 17. doi: 10.7326/L20-0725.

  6. ANDERSON MR, Geleris J, Anderson DR, Zucker J, et al
    Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Ann Intern Med. 2020 Jul 29. doi: 10.7326/M20-3214.
    PubMed         Abstract available

  7. Summary for Patients: Obesity and Risk for Adverse Outcomes Among Patients Diagnosed With COVID-19.
    Ann Intern Med. 2020 Aug 12. doi: 10.7326/P20-0011.

  8. KASS DA
    COVID-19 and Severe Obesity: A Big Problem?
    Ann Intern Med. 2020 Aug 12. doi: 10.7326/M20-5677.

  9. TARTOF SY, Qian L, Hong V, Wei R, et al
    Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.
    Ann Intern Med. 2020 Aug 12. doi: 10.7326/M20-3742.
    PubMed         Abstract available

  10. LAWANDI A, Danner RL
    Antibody tests have higher sensitivity at >/=15 days after symptom onset and 99% specificity for detecting SARS-CoV-2.
    Ann Intern Med. 2020;173:JC57.
    PubMed         Abstract available

  11. LICHTENTHAL WG, Roberts KE, Prigerson HG
    Bereavement Care in the Wake of COVID-19: Offering Condolences and Referrals.
    Ann Intern Med. 2020 Jun 23. doi: 10.7326/M20-2526.

    Antimicrob Agents Chemother

  12. SUZUKI S, Nguyen CT, Ogata-Nakahara A, Shibata A, et al
    Efficacy of a cap-dependent endonuclease inhibitor and neuraminidase inhibitors against H7N9 highly pathogenic avian influenza virus causing severe viral pneumonia in cynomolgus macaques.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01825.
    PubMed         Abstract available


  13. COBAIN M
    Covid-19's known unknowns: population shared decision making.
    BMJ. 2020;371:m4514.

    Epidemiol Infect

  14. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.

    J Epidemiol Community Health

  15. FRETHEIM A, Flato M, Steens A, Flottorp SA, et al
    COVID-19: we need randomised trials of school closures.
    J Epidemiol Community Health. 2020;74:1078-1079.

    J Exp Med

  16. SCHAFER A, Muecksch F, Lorenzi JCC, Leist SR, et al
    Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Immunol

  17. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
    SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
    J Immunol. 2020;205:3130-3140.
    PubMed         Abstract available

  18. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
    Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    J Immunol. 2020;205:2719-2725.
    PubMed         Abstract available

  19. NOWILL AE, de Campos-Lima PO
    Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    J Immunol. 2020;205:2566-2575.
    PubMed         Abstract available

    J Infect

  20. FRICKE LM, Glockner S, Dreier M, Lange B, et al
    Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
    PubMed         Abstract available

    J Virol

  21. YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
    Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade in Chickens.
    J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
    PubMed         Abstract available

  22. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
    PubMed         Abstract available

  23. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    PubMed         Abstract available

  24. PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
    Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
    J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
    PubMed         Abstract available

    J Virol Methods

  25. MICHEL D, Danzer KM, Gross R, Conzelmann C, et al
    Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA.
    J Virol Methods. 2020;286:113965.
    PubMed         Abstract available

  26. MOHON AN, Oberding L, Hundt J, van Marle G, et al
    Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2.
    J Virol Methods. 2020;286:113972.
    PubMed         Abstract available

  27. LIU M, Li Q, Zhou J, Ai W, et al
    Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.
    J Virol Methods. 2020;286:113974.
    PubMed         Abstract available

  28. ALEXANDER MR, Rootes CL, van Vuren PJ, Stewart CR, et al
    Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation.
    J Virol Methods. 2020;286:113977.
    PubMed         Abstract available

  29. ROCCA MF, Zintgraff JC, Dattero ME, Santos LS, et al
    A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs.
    J Virol Methods. 2020;286:113991.
    PubMed         Abstract available

  30. BAKRE A, Jones L, Bennett HK, Bobbitt D, et al
    Detection of Swine Influenza Virus in Nasal Specimens by Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP).
    J Virol Methods. 2020 Nov 30:114015. doi: 10.1016/j.jviromet.2020.114015.
    PubMed         Abstract available


  31. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.

  32. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed         Abstract available

    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.

  34. LERNER AM, Folkers GK, Fauci AS
    Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions.
    JAMA. 2020 Oct 26. pii: 2772459. doi: 10.1001/jama.2020.21946.


  35. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.

  36. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.

  37. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.

  38. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.

    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.

    Lancet Planet Health

  40. SHULTZ JM, Kossin JP, Ali A, Borowy V, et al
    Superimposed threats to population health from tropical cyclones in the prevaccine era of COVID-19.
    Lancet Planet Health. 2020;4:e506-e508.

    MMWR Morb Mortal Wkly Rep

  41. SELF WH, Tenforde MW, Stubblefield WB, Feldstein LR, et al
    Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1762-1766.
    PubMed         Abstract available

  42. PERRINE CG, Chiang KV, Anstey EH, Grossniklaus DA, et al
    Implementation of Hospital Practices Supportive of Breastfeeding in the Context of COVID-19 - United States, July 15-August 20, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1767-1770.
    PubMed         Abstract available

  43. FIRESTONE MJ, Wienkes H, Garfin J, Wang X, et al
    COVID-19 Outbreak Associated with a 10-Day Motorcycle Rally in a Neighboring State - Minnesota, August-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1771-1776.
    PubMed         Abstract available

  44. VAN DYKE ME, Rogers TM, Pevzner E, Satterwhite CL, et al
    Trends in County-Level COVID-19 Incidence in Counties With and Without a Mask Mandate - Kansas, June 1-August 23, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1777-1781.
    PubMed         Abstract available

  45. MCCLUNG N, Chamberland M, Kinlaw K, Bowen Matthew D, et al
    The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1782-1786.
    PubMed         Abstract available

    N Engl J Med

  46. BEIGEL JH, Tomashek KM, Dodd LE, Mehta AK, et al
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764.
    PubMed         Abstract available

  47. GOLDMAN JD, Lye DCB, Hui DS, Marks KM, et al
    Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
    N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301.
    PubMed         Abstract available

  48. CAVALCANTI AB, Zampieri FG, Rosa RG, Azevedo LCP, et al
    Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
    N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMoa2019014.
    PubMed         Abstract available

  49. PERETZ PJ, Islam N, Matiz LA
    Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2022641.

  50. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.

  51. HORBY P, Mafham M, Linsell L, Bell JL, et al
    Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926.
    PubMed         Abstract available

  52. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    N Engl J Med. 2020;383:e123.

  53. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
    Audio Interview: Covid-19 in Europe and New Information on Vaccines.
    N Engl J Med. 2020;383:e134.

    PLoS Biol

  54. KENNEDY DA, Read AF
    Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    PLoS Biol. 2020;18:e3001000.
    PubMed         Abstract available

    PLoS One

  55. KOLIN DA, Kulm S, Christos PJ, Elemento O, et al
    Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank.
    PLoS One. 2020;15:e0241264.
    PubMed         Abstract available

  56. ARONU AE, Chinawa JM, Nduagubam OC, Ossai EN, et al
    Maternal perception of masking in children as a preventive strategy for COVID-19 in Nigeria: A multicentre study.
    PLoS One. 2020;15:e0242650.
    PubMed         Abstract available

  57. KABITO GG, Alemayehu M, Mekonnen TH, Daba Wami S, et al
    Community's perceived high risk of coronavirus infections during early phase of epidemics are significantly influenced by socio-demographic background, in Gondar City, Northwest Ethiopia: A cross-sectional -study.
    PLoS One. 2020;15:e0242654.
    PubMed         Abstract available

  58. MEILER S, Hamer OW, Schaible J, Zeman F, et al
    Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism.
    PLoS One. 2020;15:e0242475.
    PubMed         Abstract available

  59. YILMAZ S, Dudkina E, Bin M, Crisostomi E, et al
    Kemeny-based testing for COVID-19.
    PLoS One. 2020;15:e0242401.
    PubMed         Abstract available

  60. WANG D, Mo J, Zhou G, Xu L, et al
    An efficient mixture of deep and machine learning models for COVID-19 diagnosis in chest X-ray images.
    PLoS One. 2020;15:e0242535.
    PubMed         Abstract available

  61. NGUYEN TT, Pham TN, Van TD, Nguyen TT, et al
    Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.
    PLoS One. 2020;15:e0242537.
    PubMed         Abstract available

  62. ZACHARIOUDAKIS IM, Zervou FN, Prasad PJ, Shao Y, et al
    Association of SARS-CoV-2 genomic load trends with clinical status in COVID-19: A retrospective analysis from an academic hospital center in New York City.
    PLoS One. 2020;15:e0242399.
    PubMed         Abstract available

  63. IZCOVICH A, Ragusa MA, Tortosa F, Lavena Marzio MA, et al
    Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
    PLoS One. 2020;15:e0241955.
    PubMed         Abstract available

  64. KRISHNAMURTHY HK, Jayaraman V, Krishna K, Rajasekaran KE, et al
    Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.
    PLoS One. 2020;15:e0242655.
    PubMed         Abstract available

  65. POYNARD T, Deckmyn O, Rudler M, Peta V, et al
    Performance of serum apolipoprotein-A1 as a sentinel of Covid-19.
    PLoS One. 2020;15:e0242306.
    PubMed         Abstract available

  66. HOWLAND RE, Cowan NR, Wang SS, Moss ML, et al
    Public transportation and transmission of viral respiratory disease: Evidence from influenza deaths in 121 cities in the United States.
    PLoS One. 2020;15:e0242990.
    PubMed         Abstract available

  67. CENTO V, Alteri C, Merli M, Di Ruscio F, et al
    Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy.
    PLoS One. 2020;15:e0242765.
    PubMed         Abstract available

  68. STOHR E, Aksoy A, Campbell M, Al Zaidi M, et al
    Hospital admissions during Covid-19 lock-down in Germany: Differences in discretionary and unavoidable cardiovascular events.
    PLoS One. 2020;15:e0242653.
    PubMed         Abstract available

  69. ALSHUKRY A, Ali H, Ali Y, Al-Taweel T, et al
    Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait.
    PLoS One. 2020;15:e0242768.
    PubMed         Abstract available

  70. PAUL D, Gupta A, Maurya AK
    Exploring options for reprocessing of N95 Filtering Facepiece Respirators (N95-FFRs) amidst COVID-19 pandemic: A systematic review.
    PLoS One. 2020;15:e0242474.
    PubMed         Abstract available

  71. MEJDOUBI M, Kyndt X, Djennaoui M
    ICU admissions and in-hospital deaths linked to COVID-19 in the Paris region are correlated with previously observed ambient temperature.
    PLoS One. 2020;15:e0242268.
    PubMed         Abstract available

  72. SHARIFPOUR M, Rangaraju S, Liu M, Alabyad D, et al
    C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19.
    PLoS One. 2020;15:e0242400.
    PubMed         Abstract available


  73. EDOKA I, Kohli-Lynch C, Fraser H, Hofman K, et al
    A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31468.
    PubMed         Abstract available


  74. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.